Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IGC Pharma (IGC) FCF Margin (2016 - 2025)

IGC Pharma (IGC) has disclosed FCF Margin for 16 consecutive years, with 1109.42% as the latest value for Q3 2025.

  • Quarterly FCF Margin fell 86064.0% to 1109.42% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 508.68% through Sep 2025, down 8510.0% year-over-year, with the annual reading at 386.07% for FY2025, 1073.0% up from the prior year.
  • FCF Margin for Q3 2025 was 1109.42% at IGC Pharma, down from 431.4% in the prior quarter.
  • The five-year high for FCF Margin was 183.39% in Q1 2024, with the low at 4167.86% in Q3 2021.
  • Average FCF Margin over 5 years is 1092.77%, with a median of 671.69% recorded in 2022.
  • Peak annual rise in FCF Margin hit 613201bps in 2021, while the deepest fall reached -197026bps in 2021.
  • Over 5 years, FCF Margin stood at 1724.65% in 2021, then skyrocketed by 61bps to 671.69% in 2022, then dropped by -21bps to 811.27% in 2023, then soared by 36bps to 522.96% in 2024, then crashed by -112bps to 1109.42% in 2025.
  • According to Business Quant data, FCF Margin over the past three periods came in at 1109.42%, 431.4%, and 226.67% for Q3 2025, Q2 2025, and Q1 2025 respectively.